Switzerland· 22562001
Kemadrin, Tabletten
A procyclidine product, registered in Switzerland by Aspen Pharma Schweiz GmbH and dispensed under Swissmedic category B. The same ATC class is registered in 8 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Procyclidine is registered in 8 of 19 countries.
Countries holding a registration under ATC N04AA04 (procyclidine), each read from that country’s own register.
- This record: Switzerland
- 4 of them publish a price we can compare per daily dose
Procyclidine · ATC N04AA04
8 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Norwayprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of procyclidine costs, country by country.
Normalised to the WHO defined daily dose (25 mg), so markets compare like for like.
- Switzerland: $1.57 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Procyclidine · price per daily dose (25 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.57
The record
At a glance
- Manufacturer
- Aspen Pharma Schweiz GmbH
- Country
- Switzerland (CH)
- ATC code
- N04AA04
- ATC class
- Procyclidine
- Defined daily dose
- 25 mg, O
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
89 interactions on record for procyclidine.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Procyclidine · interactions on record
89 records
- 3 severe
- 85 moderate
- 1 minor
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- DicycloverineA03AA07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N04AA04
Procyclidine, as other registers publish it.
- United KingdomArpicolin 2.5mg/5ml oral solutionRosemont Pharmaceuticals Ltd
- United KingdomArpicolin 5mg/5ml oral solutionRosemont Pharmaceuticals Ltd
- NorwayKemadrinGlaxoSmithKline
- SwitzerlandKemadrin
- FinlandKemadrinThe Wellcome Foundation Limited
- DenmarkKemadrinAspen Pharma Trading Ltd.
- United KingdomKemadrin 10mg/2ml solution for injection ampoulesAuden McKenzie (Pharma Division) Ltd
- BelgiumKemadrin 5 mgAspen Pharma Trading
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/badcba26-c97a-47cb-9747-b1fcc12ce6ba GET /v1/drugs/badcba26-c97a-47cb-9747-b1fcc12ce6ba?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about procyclidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.